World's Best Scientists 2026 revealed!
Torsten Pietsch

Torsten Pietsch

D-Index & Metrics

Medicine

D-Index
124
Citations
58482
World Ranking
3218
National Ranking
173

Research.com Recognitions

  • 1996 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Torsten Pietsch is affiliated with the University of Bonn in Germany. Their research spans areas primarily within medicine and biochemistry, genetics, and molecular biology. Their work is concentrated in several subfields including genetics, molecular biology, neurology, pulmonary and respiratory medicine, and epidemiology.

The main topics of their research cover:

  • Glioma Diagnosis and Treatment
  • Neuroblastoma Research and Treatments
  • Brain Metastases and Treatment
  • Meningioma and schwannoma management
  • Chromatin Remodeling and Cancer
  • Hedgehog Signaling Pathway Studies
  • Radiomics and Machine Learning in Medical Imaging

Pietsch has contributed to numerous highly specialized publications. Some recently published papers include:

  • "cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading", 2020, Brain Pathology
  • "Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes", 2020, Cancer Discovery
  • "Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology", 2023, Nature Medicine
  • "Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort", 2020, Journal of Clinical Oncology
  • "Supratentorial ependymoma in childhood: more than just RELA or YAP", 2021, Acta Neuropathologica

The frequent publication venues for their work are:

  • Neuro-Oncology
  • Acta Neuropathologica
  • Neuro-Oncology Advances
  • Journal of Neuro-Oncology
  • Journal of Clinical Oncology

Collaborations play a significant role in their research activities. Frequent co-authors include:

  • Stefan Rutkowski
  • Brigitte Bison
  • Stefan M. Pfister
  • Martin Mynarek
  • Monika Warmuth-Metz

Pietsch was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 1996.

Best Publications

  • DNA methylation-based classification of central nervous system tumours

    David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt

  • Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias.

    Walter Stummer;Hanns-Jürgen Reulen;Thomas Meinel;Uwe Pichlmeier

  • Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors

    Barbara Lustig;Boris Jerchow;Martin Sachs;Sigrid Weiler

  • Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

    Roger Stupp;Roger Stupp;Monika E Hegi;Thierry Gorlia;Sara C Erridge

  • Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

    Marcel Kool;Andrey Korshunov;Marc Remke;Marc Remke;David T.W. Jones

  • Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups

    Kristian W. Pajtler;Kristian W. Pajtler;Hendrik Witt;Martin Sill;David T.W. Jones

  • Long-term survival with glioblastoma multiforme

    Dietmar Krex;Barbara Klink;Christian Hartmann;Andreas Von Deimling

  • Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: Implications for classification of gliomas

    Christian Hartmann;Christian Hartmann;Bettina Hentschel;Wolfgang Wick;Wolfgang Wick;David Capper

  • New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

    Dominik Sturm;Dominik Sturm;Brent A. Orr;Umut H. Toprak;Volker Hovestadt

  • NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide

    Wolfgang Wick;Christian Hartmann;Corinna Engel;Mandy Stoffels

  • Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features

    Marcel Kool;Jan Koster;Jens Bunt;Nancy E. Hasselt

  • Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone

    Stefan Rutkowski;Udo Bode;Frank Deinlein;Holger Ottensmeier

  • Treatment of brain tumors

    Arnold C. Paulino;Bin S. Teh;Michelle Sadeh;Lynn Ashby

  • Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network

    Michael Weller;Jörg Felsberg;Christian Hartmann;Hilmar Berger

  • International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

    David N. Louis;Arie Perry;Peter Burger;David W. Ellison

  • Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

    Paul A. Northcott;Catherine Lee;Catherine Lee;Thomas Zichner;Adrian M. Stütz

  • High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

    Eckhard Thiel;Agnieszka Korfel;Peter Martus;Lothar Kanz

  • Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma

    Roger Stupp;Monika E. Hegi;Bart Neyns;Roland Goldbrunner

  • NeuN: a useful neuronal marker for diagnostic histopathology.:

    H K Wolf;R Buslei;R Schmidt-Kastner;P K Schmidt-Kastner

  • Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy Alone

    Stefan Rutkowski;Udo Bode;Frank Deinlein

Frequent Co-Authors

Stefan Rutkowski
Stefan Rutkowski Universität Hamburg
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Andreas von Deimling
Andreas von Deimling Heidelberg University
Guido Reifenberger
Guido Reifenberger Heinrich Heine University Düsseldorf
Michael Weller
Michael Weller University of Zurich
Andrey Korshunov
Andrey Korshunov German Cancer Research Center
Marcel Kool
Marcel Kool German Cancer Research Center
David T. W. Jones
David T. W. Jones German Cancer Research Center
David Capper
David Capper Charité - University Medicine Berlin
Manfred Westphal
Manfred Westphal Universität Hamburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens the door to a broad range of online degree options and specialized pathways. For those seeking fast entry into the healthcare field, lpn programs can be completed in less time than traditional programs, allowing graduates to start working and gaining experience quickly.

Many medical professionals are turning to advanced online degrees to further their expertise. If mental health interests you, online msn pmhnp programs prepare nurses for in-demand roles in psychiatric care, offering flexible online study with clinical experience.

Not all medical careers require a clinical background. Administrative paths like a cheapest online healthcare administration degree provide cost-effective routes into the business side of healthcare, managing operations or leading teams.

For career advancement in leadership and policy, the cost of mha degree is a key factor to consider, with many affordable options available online. These degrees can fast-track your move into higher management roles.

Best Scientists Citing Torsten Pietsch

Trending Scientists